Updated 2026-11-16. Refreshed weekly (see How this page stays current at the bottom).
This week (checked 2026-11-16, window 10 to 16 Nov)
- Tape: two new episodes swept. Moonshots #310 (aired 11 Nov) carried the cancer read, with the chief medical officer on camera (caption "Dr. Don Mucalem"), at
2:05:49–2:07:55: "It turns out 3.3% of them have a cancer in their body they don't know about" (2:06:33), "over 3.3% were found to have these cancers" (2:06:53–2:07:04), and the same caveat, "these are not studies that insurance would yet be covering" (2:07:34). A repeat, no new figure. The caption text matches the Moonshots #305 read word for word, so it reads as the same recorded segment aired again. Moonshots #311 (aired 13 Nov) has no Fountain Life read: the name does not appear in its transcript. Counts now: A 13, B 16, cardiac 12, cancer 15. Bounded: EP310 and EP311 were swept for this page; whether anything aired after 13 Nov was not checked. - Their numbers: unchanged. Home page (4x, 56%, 46%, 52%, 3.5%, 12%), /core and /apex (4x, 80%, 96%, 56%, 46%; "8 / 24 / 3 of 27 covered") and /how-it-works (99.8%, 31%, 50%+, 100%) all as last week. Still no 26% on any of the six pages checked. /base still serves the general memberships page (no BASE tier, no $595, no "Texas and Florida"). The menu still lists five centres open (Dallas, New York, Orlando, Naples, Houston), Miami and Los Angeles "coming soon".
- Award badges: four, not two. Besides "Two-Time Winner Longevity Center of the Year 2025 & 2026" and "Miami Herald Best Longevity Clinic of the Year 2026", the home, /how-it-works, /core and /apex pages carry "Winner 2025 Global Tech Awards in the Health Category" and "Athletech News Most Innovative Fitness & Wellness Companies of 2026". These two are recorded here for the first time; whether they were up on 10 Nov is not recorded. ⚠ The Miami Herald, Global Tech Awards and Athletech awards are all unverified: one web search found no issuer source for any of them. Note also that the badge says Longevity Center of the Year; their own 22 Oct release says Longevity Clinic of the Year.
- /news: unchanged. 9 pages; the newest item is still the 22 Oct award release. Nothing published after 22 Oct.
- Prices: not re-checked, third week running. shop.fountainlife.com/products.json returned HTTP 429 (Retry-After 60) on three spaced requests. Every price on this page still carries its 2026-10-29 date.
- Publications: a ninth paper, not a member study. PubMed
"Fountain Life"[Affiliation]now returns 9 (8 last week). The new one, indexed 16 Nov: "Prevalence and Characteristics of Potential QT-Interval-Prolonging Drug-Drug Interactions in Patients Receiving Oral Anticancer Drugs", Pharmacotherapy 46(12), Dec 2026, doi:10.1002/phar.70217: a retrospective health-record study of 3,697 patients with advanced cancer, with one co-author listing Fountain Life, Inc. (Indianapolis). It belongs with the earlier pharmacogenomics papers. It reports none of the 88%, 46%, 26%, 3.3% or 50%+ figures. - 2025 HbA1c item: one web search found no Fountain Life member study on HbA1c and coronary disease, only the general literature. Still unpublished as far as can be found. Bounded: one search.
- Franchise: no open call, no franchise mention on their site, no new centre. Two searches returned only the 2024–2026 opening and funding reports already known. The window is still about Mar to Jun 2027, per EP289.
- Open: the method behind the 88/46/26 figures has not been published. No open programme, prize, grant or call was found (the badges are past honours, not calls), so there is no pipeline or operator-guide row this week.
Previous week (checked 2026-11-10, window 4 to 10 Nov)
- Tape: two new episodes, both carrying a brain-age read, both repeats, no new figure. Moonshots #308 (aired 4 Nov) carried read A (46%) at
1:19:03–1:21:02; its captions are machine-translated, so the wording is rough and the CMO's name comes out as "Don Saladino" (logged in the EP308 section below). Moonshots #309 (aired 7 Nov) carried read B (26%), said on camera by the chief medical officer (caption "Don musalem"), at1:25:03–1:27:02: "45 percent are entirely preventable" (1:26:09), "One quarter of our members had advanced brain age" (1:26:20), "we improved that brain age by 26 … the majority of those individuals" (1:26:32–1:26:45). The CTA is fountainlife.com/peter. The swap happened again: read A on 4 Nov and read B three days later, both from the same medical lead. Counts now: A 13, B 16, cardiac 12, cancer 14. The watcher ran on 2026-11-10: 111 episodes on disk, none missing. - Their numbers: unchanged. Home page (4x, 56%, 46%, 52%, 3.5%, 12%; 150 GB; the stem-cell banner with its "not FDA approved" note; no franchise mention), /core and /apex (4x, 80%, 96%, 56%, 46%; "8 / 24 / 3 of 27 covered") and /how-it-works (99.8%, 31%, 50%+, 100%, 150 GB) all as last week. Still no 26% on any of those five pages. /base still serves the general memberships page (no BASE tier, no $595, no "Texas and Florida"). The menu still lists five centres open, with Miami and Los Angeles "coming soon".
- New on their pages: award badges. Every page now carries "Two-Time Winner Longevity Center of the Year 2025 & 2026" (the Roundtable of Longevity Clinics award covered last week) and an awards block that reads "Miami Herald Best Longevity Clinic of the Year 2026". ⚠ The Miami Herald award is unverified. One web search found no Miami Herald source for it. Whether the badge was already up on 4 Nov is not recorded.
- /news grew backwards. It now runs to 9 pages (8 on 29 Oct). Page 1 lists twelve items dated 7 Jun to 22 Oct 2026, and nine of them fall in a stretch where the 29 Oct check found nothing newer than 5 Jun. They read as reposts of third-party coverage, posted with their original dates: Houston's "Best of the City 2026" (5 Aug), "Inside New York's / Dallas' Top Longevity Destination" (31 Aug), and "Celularity, Fountain Life to offer experimental cell therapy in Florida" (8 Jun). The newest item is still the 22 Oct award release. Nothing published after 22 Oct.
- Prices: not re-checked this week. shop.fountainlife.com/products.json returned HTTP 429 (Retry-After 60) on four requests across two tries. Every price on this page still carries its 2026-10-29 date.
- Publications: PubMed
"Fountain Life"[Affiliation]is still 8, with nothing new. Still nothing for the 88%, 46%, 26% or the 50%+. - 2025 HbA1c item: one web search found no Fountain Life member study on HbA1c and coronary disease, only the general literature. Still unpublished as far as can be found. Bounded: one search.
- Franchise: no open call, no franchise mention on their site, no new centre. One search returned only the 2022–2025 opening reports already known. The window is still about Mar to Jun 2027, per EP289.
- Open: the method behind the 88/46/26 figures has not been published. No open programme, prize, grant or call was found (both awards are past honours, not calls), so there is no pipeline or operator-guide row this week.
Last successful price check (2026-10-29)
- Prices: re-checked, unchanged. shop.fountainlife.com/products.json answered this week (it was rate-limited on 23 Oct): 129 listings, no new product created since the two Holiday Gift Cards (Dec 2025). CORE $10,500, APEX $23,500, the four final-payment listings ($7,000 / $14,500 / $18,000 / $16,000), full-body and brain MRI $2,250, CCTA $900, multi-cancer test $949, biological age $750, p-Tau217 $595, DEXA add-on $95, plasma exchange $10,000, placental stem-cell IV $1,500; the A360 packages still unavailable. Every listing carries the same
updated_attimestamp (29 Oct), which reads as a store-wide refresh, not a price change. The BASE $595 still cannot be confirmed anywhere on fountainlife.com.
What it is: Peter Diamandis's diagnostic-longevity clinic business, a standing sponsor of Moonshots with Peter Diamandis, and, as of EP289, a franchise he is opening to outside operators. It is the one company on that show that is simultaneously an ad, a disclosure, a health claim and a business opportunity with a date on it.
Nothing on this page is medical advice. It describes what a company says and sells, and what it has and has not published.
Why it is in this archive
Gate: 75 of 109 indexed episodes, 258 mentions (ROLLUP, 2026-11-10, through Moonshots #309; it was 60 of 86 and 196 when the page was created), the promotion threshold in the research archive, cleared several times over. It earned the page on EP289 specifically, because that is the first time the sponsor is described on tape as an operating business with a footprint, a partner and an opening date, rather than as a read.
It also sits directly on a Gonçalo lane: the longevity lab is building a studio functional-age test base. Fountain Life is the closest thing to a reference implementation, the nearest competitor, and the loudest source of numbers we are not allowed to use.
The data behind the numbers
The question this section answers: for every number said on tape, where has Fountain Life published the data behind it? Checked 2026-09-29 against fountainlife.com (home, membership, CORE, APEX, BASE, how-it-works), Fountain Life's 6 January 2026 press release on PR Newswire, and PubMed.
The headline: two brain-age numbers, both in rotation for six months
There are two different pre-taped brain-age reads, and they alternate on the show:
| Read | What the tape says | Aired | First → last |
|---|---|---|---|
| A | "over 13 months … we were able to improve the brain age in 46% of those individuals. That's a powerful number." | 10 episodes, + the 15 Oct 2026 episode (1:13:44–1:15:22, the 46% line at 1:14:53; this time said on camera by the chief medical officer, Dr. Dawn Mussallem, DO, transcript spelling "Musalem"; appointed Dec 2025 per trade press, secondary), + Moonshots #307 (31 Oct 2026, 1:40:49–1:42:41, the 46% line at 1:42:07, the CMO on camera), + Moonshots #308 (4 Nov 2026, 1:19:03–1:21:02, machine-translated captions): 13 |
EP248 (18 Apr 2026, 0:48:26) → EP290 (15 Sep, 0:37:50) → Moonshots #308 |
| B | *"we improved that brain age by 26%. That is a big, big number to show that the majority of those individuals were able actually to improve the brain age."* | 13 episodes, + Moonshots #303 (aired 17 Oct 2026, 0:57:13–0:58:40, the 26% line at 0:58:06; said on camera by the same chief medical officer, caption "Don Malem") + Moonshots #304 (aired 21 Oct 2026, 1:36:45–1:38:33, the 26% line at 1:38:13, same CMO, caption "Don Mussalem") + Moonshots #309 (aired 7 Nov 2026, 1:25:03–1:27:02, the 26% line at 1:26:32, same CMO, caption "Don musalem"): 16 |
EP240 (21 Mar 2026, 0:57:28) → EP298 (2:00:22) → Moonshots #309 |
Both open on the same set-up ("one quarter of our members had advanced brain age"). They are not one number misread: they are two recordings, and they do not describe the same thing. A is a share of people (46% of those with advanced brain age improved). B is phrased as a size of improvement ("by 26%") and then called "the majority", which 26% is not. Aired back to back, they are two days apart (EP290 on 15 Sep, EP291 on 17 Sep). It happened again in October, and now in one voice: the chief medical officer says read A on the 15 Oct episode and read B on Moonshots #303 (17 Oct). Both numbers now come from the company's own medical lead on camera, two days apart.
What Fountain Life has published: the 46% only. The site says "46% Achieve brain age improvement, reversing accelerated aging" (CORE, APEX and BASE pages) and the January 2026 release says "Nearly 1 in 4 members show accelerated brain aging at baseline" and "46% reverse accelerated brain aging." The company's 22 Oct 2026 award release repeats the same pair (nearly 1 in 4 at baseline, 46% improving on follow-up). The 26% appears on no Fountain Life page or release found. Neither figure comes with a study, a denominator, the brain-age method (which MRI software, what counts as "improved"), a follow-up interval beyond "13 months" on tape, or a comparison group. → Not published.
Every number on tape, and what stands behind it
| Claim, as said on tape | Aired (in the 91 episodes on disk) | What Fountain Life has published | Method / denominator | Status |
|---|---|---|---|---|
| Brain age improved in 46% | 13×, Apr–Nov 2026 (latest Moonshots #308, 4 Nov, 1:19:03–1:21:02) |
Site + Jan 2026 and 22 Oct 2026 releases: "46%" | None published | Company figure, method not published |
| Brain age improved by 26%, "the majority" | 16×, Mar–Nov 2026 (latest Moonshots #309, 7 Nov, 1:26:32, the CMO on camera) |
Nothing found | None | Not published |
| 88% of people coming in have detectable coronary artery disease (CT angiography with AI) | 12×, EP247 (14 Apr 2026) → Moonshots #306 (28 Oct 2026, 1:46:36, the CMO on camera) |
Jan 2026 release: "88% of members show early signs of coronary plaque" | No denominator: how many members had the scan, their ages, symptom status, or the threshold for "detectable" | Company figure, no denominator |
| 23% of those had soft plaque | same read, 12× | Nothing found | None | Not published |
| 3.3% of members who think they are healthy have a cancer they don't know about | 14×, EP242 (26 Mar 2026) → Moonshots #305 (23 Oct 2026, 1:45:46) |
Jan 2026 release: "up to 3.4%"; site: "4x" higher cancer detection | No denominator; the "4x" comparator is not named | Company figure, three versions |
| 45% of dementia cases "entirely preventable" | in both brain-age reads | not a Fountain Life figure | External source exists: the 2024 Lancet Commission (Livingston et al., Lancet 404:572–628) puts ~45% of dementia as potentially preventable or delayable by addressing 14 modifiable risk factors, at population level | Real figure, misworded on tape |
| 50% of people die of heart attacks with no warning signs | cardiac read, 2026 | not a Fountain Life figure | No source cited on tape | Unsourced (latest Moonshots #306, 1:46:16, the CMO). Also moved: the 2025 read (EP177–EP185, Jun–Jul 2025) said "70% of heart attacks have no precedent … half of those people … never wake up" |
| 30,000 people reached out for memberships after Life Force | EP170, EP172, EP215, EP240 | nothing found | Self-reported | Not published |
Numbers Fountain Life publishes that are not on tape
Same test: none of these comes with a method or a denominator on the page that states it.
| Figure | Where | Note |
|---|---|---|
| 96% "detect potentially life-threatening diseases before symptoms appear" | CORE / APEX / BASE pages | Share of what, over what period: not stated |
| 80% "achieve measurable health improvements" | CORE / APEX / BASE pages | Dec 2025 coverage adds "within 1.3 to 1.8 years" |
| 56% "improve core brain health" | site | Dec 2025 coverage describes the same 56% as "improvement in deep white matter brain lesions". Same number, two definitions |
| Plaque outcome | four versions | Home page "12% significant plaque reversal"; how-it-works "31% of Members stabilized or reversed dangerous cardiac plaque"; Jan 2026 release "26% of members halt disease progression" and "6% experience plaque regression" (both repeated in the 22 Oct 2026 award release). Four figures for one outcome across their own material. (A 26% does exist in their published numbers, for plaque. Whether that is where the tape's brain-age 26% came from cannot be told from outside; it is a question, not a finding.) |
| 52% liver-fat normalisation · 3.5% aneurysm detection | site | No method |
| 99.8% "success when cancers are caught at stage 1" · "100% Reported renewed energy" | how-it-works | Rhetorical: no source |
| 50%+ "reversed early signs of heart disease, diabetes, or cognitive decline through precision care" | how-it-works | First recorded here 2026-10-17 (the 5 Oct fetch was not kept verbatim, so whether it was already there is not known). Three conditions pooled into one share; no denominator, no interval, no definition of "reversed" |
| 15+ billion data points, 8,000+ members · 51% of prediabetic members back to normal glucose in 1.2 years · 64% of diabetic members improve | Jan 2026 release | The 8,000 is the only membership count they publish |
| "$20 million in annual net benefit per 1,000 members", "13:1" ROI | Executive Health, Dec 2025 coverage | A company model, not a measured outcome |
What Fountain Life has published in peer review
PubMed lists nine papers with a Fountain Life affiliation (2024–2026; the eighth, a lifestyle-medicine review in cancer care, appeared 2026-10-05; the ninth, a QT-interval drug-interaction study in Pharmacotherapy, was indexed 2026-11-16). None reports the member outcomes above. They are: a multiomics case report on an early pancreatic lesion (OMICS, 2024); a co-authorship on GRAIL's real-world study of 111,080 Galleri multi-cancer tests (Nature Communications, 2025), which is GRAIL's data, not Fountain Life's members; and six pharmacogenomics, drug-interaction and cancer-sequencing papers. Bounded: this is an affiliation search; a paper that omits the affiliation would not show up.
The tape says as much itself. EP262 0:54:14, the cancer read: "these are not studies that insurance
would yet be covering. But the goal is to collect these numbers, do the research, and work hard to
democratize wellness." On the company's own account, the research behind the numbers is still to come.
How the model works
Checked at fountainlife.com and shop.fountainlife.com on 2026-09-29. Primary = the company's own pages. Prices change; each is dated.
The member journey, in their order (fountainlife.com/how-it-works)
- Discovery call, to choose a tier.
- Initial consultation: history, goals, lifestyle.
- Diagnostics day: "150 GB of your health data points": imaging, blood, genetics, by tier.
- A personalised plan, plus the Zori AI app (an AI "medical expert" over the member's own data).
- Ongoing check-ins and coaching.
- Restorative therapeutics, the treatments sold on top.
- Annual renewal: repeat the diagnostics.
Detect, plan, treat, re-test. Step 7 is the business: the annual re-scan is what renews the membership, and step 6 is where the à-la-carte revenue sits.
What is measured (the membership table lists 27 "AI-Guided Diagnostics")
| Category | Tests |
|---|---|
| Imaging | Full-body and brain MRI with AI · coronary CT angiography (CCTA) with AI · low-dose lung CT · DEXA (bone density, body composition) · retinal scan with AI · skin mapping with AI |
| Labs | 100+ marker blood panel · multi-cancer early-detection blood test · epigenetic biological age · cellular senescence and immune age · gut microbiome · oral pathogens · environmental toxicants · nutrition · hormone and cortisol rhythm |
| Genomics | Whole-genome sequencing |
| Wearables / home | Continuous glucose monitor · home sleep test |
| Physiology | Blood pressure · ECG · pulse wave velocity (arterial stiffness) |
| Function | VO₂max · grip strength · balance · functional movement and mobility |
| Cognition and senses | Computerised neurocognitive test (memory, attention, processing speed, executive function, reaction time) · olfactory test |
The tiers, and what each one includes
| Tier | Price (dated) | Source | What it covers |
|---|---|---|---|
| BASE | $595 a year (2026-09-29; unchanged 2026-10-17) | fountainlife.com/base | 100+ marker blood panel (Quest), DEXA, a clinician review through Zori AI, a year of the app. Self-serve online sign-up, no staff involved. Sold also through corporate partners, private and country clubs, and community / affinity groups. The page said it was "currently available at Fountain Life centers in Texas and Florida", other states "launching soon" (2026-10-17). On 2026-10-23, /base served the general memberships page instead, with no BASE tier on it. The status of BASE is unknown |
| CORE | $10,500 (listing "CORE Diagnostics", 2026-09-29) | shop.fountainlife.com | 8 of the 27: full-body and brain MRI, DEXA, blood panel, CCTA, ECG, lung CT, whole genome, blood pressure |
| APEX | $23,500 (listing "APEX Membership", 2026-09-29) | shop.fountainlife.com | Header says 24 of 27, and adds the retinal, skin, gut, toxicant, epigenetic, neurocognitive, function (VO₂max, grip, balance, movement), sleep and olfactory tests, plus access to therapeutics and 24/7 "Always-on Care" |
| APEX Family | no public price | fountainlife.com/apex-family | Children aged 18–30: MRI, DEXA, blood panel |
| Executive Health | no public price | fountainlife.com/executive-health | Employer programme |
The shop also carries "Final Payment" listings (APEX $14,500, CORE $7,000), which suggests a deposit-plus-balance structure; the terms are not published. Listing prices are not necessarily what is quoted on a call. TechCrunch put APEX at $21,500 on 13 Aug 2025 (secondary).
À la carte, from the same shop (2026-09-29): full-body and brain MRI with AI $2,250 · CCTA $900 · multi-cancer early-detection test $949 · biological age test $750 · A360 Brain Longevity package $2,500 · p-Tau217 blood test $595 · DEXA add-on $95. All re-checked 2026-10-17, unchanged (the A360 packages show as unavailable since 11 Oct).
The catalogue is 129 listings, not 30 (2026-10-17). The shop feed's default page is 30 items, and the earlier counts on this page were that page cap, not the catalogue. Fetched with the cap lifted, the rest is mostly skincare, fillers and IV drips, plus a few items that matter for the model: therapeutic plasma exchange $10,000, a "LifeOmic Platform" listing $10,000, lipid therapy $3,750, CCTA with Cleerly and lung AI $2,100, low-dose lung CT $146, an "APEX Elite (Pro-rate)" $2,500, "SNAP" final payments ($6,700 / $8,200), an "APEX 2025" final payment $18,000, and APEX and CORE "Holiday Gift Cards" at the membership price. Creation dates on these run 2024 to 2025, so they were there all along, unseen. What they add: the final-payment listings now show four generations (CORE $7,000; APEX $14,500; APEX 2025 $18,000; APEX+ $16,000), which is the clearest public trace of how the membership price has moved.
How it makes money
- Annual memberships, four price points from $595 to $23,500, renewed by the annual re-test.
- À-la-carte diagnostics, each test priced on its own.
- Therapeutics and aesthetics: plasma exchange, PRP and "biologic" injections, placental stem-cell IV (the site marks its stem-cell therapy "not FDA approved"), hair restoration, fillers, a skincare line.
- Channels: employers (Executive Health), clubs and affinity groups (BASE).
- Software: Zori AI, bundled in every tier.
- Licensing the system: the franchise of "the operating system and the AI systems" (EP289) and a "clinic development" programme that trains other facilities in its methods (reported with the $18M Series B led by EOS Ventures, TechCrunch 13 Aug 2025; secondary).
The structural read: the cheap physical-function tests (grip, balance, VO₂max, movement, the cognitive test) are APEX-only. The $10,500 tier is imaging, blood and genome. The measurements a training floor can do are packaged inside the $23,500 membership.
What a studio or small operator can take
Generic, and not medical advice. Screening and tracking, never diagnosis: a flag means see a clinician. Norm sources are the ones in the Gonçalo Longevity Lab's norm table.
Cheap, validated and repeatable at a training studio
| Measure | Kit | Published norms | Repeatable |
|---|---|---|---|
| Grip strength | hand dynamometer | CLSA (n≈25,000), NIH Toolbox; EWGSOP2 cut-offs | yes, minutes |
| Gait speed (4 m) | tape + stopwatch | CLSA; EWGSOP2 | yes |
| Five-times sit-to-stand | chair + stopwatch | EWGSOP2 (>15 s flag) | yes |
| Timed Up and Go | chair + stopwatch | CLSA | yes |
| Single-leg balance | stopwatch | CLSA age/sex percentiles | yes |
| Processing speed, executive function, memory | paper: SDMT, Trail Making A/B, CERAD word list | ASPREE, Tombaugh 2004, HUNT/CERAD. Norm by age and education | yes |
| Dual-task gait (walk while naming animals) | stopwatch | directional only (Montero-Odasso 2018; Tang 2020 meta) | yes: a flag, not a cut-off |
| VO₂ proxy | step or walk test | FRIEND norms are for measured VO₂max, so a field test is an estimate | yes, labelled as an estimate |
| Blood pressure | validated automatic cuff | clinical thresholds | yes: screening only |
Possible, not yet normed here: computerised reaction-time tests and smell tests. Tools exist; the Gonçalo norm table has no verified source for either yet.
Needs a clinic: every imaging test (MRI, CCTA, lung CT, DEXA, which is the gold standard for body composition), every blood, genome and epigenetic test, ECG interpretation, pulse wave velocity, sleep studies and anything therapeutic.
Two rules carried over: report each test as a percentile against its own norm ("grips like the median 55-year-old"), and never fuse them into one "biological age". A single fused number is exactly the kind of figure this page cannot find the method for.
What was said on tape
The franchise plan: EP289 (AMA) 0:12:23–0:13:21
A caller (John, Sydney) asks what role trusted local physicians play in carrying Fountain Life internationally, mentioning a clinic in Athens. Peter answers with the operating plan:
"We're Fountain Life is be going to begin um a uh a franchising model. So right now we've built five and we're building two more in the US and then we have a partnership to put them into a group of resorts called the estates. But what I really want to do is enable uh the operating system and the AI systems we built to be franchised. I think that's probably at least six to nine months away from being an open call for interest."
And on geography: "I've been to Greece to talk with a number of people about getting a Fountain
Life Center in there. I'm hoping that Greece will set its purpose beyond just olives and shipping
to uh to longevity as well." (0:13:07)
The product being franchised is not the clinic, it is the operating system. "enable the operating system and the AI systems we built to be franchised." That is the sentence to read twice.
→ Date to track: an open call for interest, ~March–June 2027 (six to nine months from the episode). Nothing to do now except watch for it.
Nano villages: EP289 (AMA) 0:58:30–0:59:02
A caller running a glamping business describes wanting to help people "reconnect to themselves and each other". A panelist answers:
"deepening human connection is about the most important thing we could do today in an age of increasing technology, right? That connective tissue is going to be critical. There's a team in our community that's building nano villages in exurban areas that they were almost like a kibutz but instead of being like isolationist like many of these are, could you network them together and collectively solve problems, right? And so they're actually literally starting to build those in different parts of the world."
Later in the same AMA (1:05:03–1:06:17) a caller interested in blue zone research asks about
planned communities built around clean eating, sunshine, exercise and faith. The answer: "I don't
offhand. I know they're being built … there are I think a multitude of longevity communities being
built." No community is named, on tape or in the chat as captured.
The idea is older than the AMA. At a live event, EP261 (3 Jun 2026) 1:08:33–1:09:15: "if you
think about solar energy, vertical farming, satellite internet, you put those together, a small
community can be self-sufficient … In the past … they tend to be isolationist … we're going to have a
kibutz. We're going to have a commune … there's some work being done in our ecosystem around this to
create [netw]orked uh communities almost like network kibitzes where you learn from each other."
⚠ Speaker unverified. Auto-captions carry no speaker labels. Both passages use the same phrasing ("connective tissue", "our community / our ecosystem", the networked kibbutz), which points to one panelist; the attribution has not been checked against the video. The team building the "nano villages" is not named on tape.
The ads: the "health section of Moonshots"
Pre-taped, voiced by Peter with Fountain Life's chief medical officer (the name is spelled several ways in the captions). Three reads rotate: cardiac (88% / 23%), cancer (3.3%), and the two brain-age reads (46% and 26%) above. Every number in them is in the data table, with its status.
🔴 Barred from Gonçalo copy (fails feedback no soft numbers): every figure in the data table whose status is anything other than an external, cited source. These are sponsor claims about a selected, self-paying membership population, with no published method, no denominator and no control. The 88% in particular is a denominator artefact until shown otherwise: people who buy an advanced cardiac scan are not a random sample. They appear on this page only as audit items. Never use them in copy as a fact or a selling point, and not even attributed, because quoting a marketing percentage launders it. If the underlying point is needed, source the general epidemiology independently and state it in our own numbers. For dementia, cite the Lancet Commission, not the tape.
The disclosure problem this page exists to hold
On EP289, inside 86 minutes: Fountain Life is read as an ad (1:10:17), offered as a business
opportunity in answer to a listener's question (0:12:34), and described by the host as "a part
of my medical team" (standing, Moonshots #283). "Not financial advice" is said zero times in
that episode. None of this is concealed (Peter says he co-founded it, and the site lists him as
co-founder), but nothing on tape separates the three registers. Anyone taking the franchise seriously
is taking it from the person selling it, on a show he hosts, next to an ad he voiced.
→ Moonshots: the disclosures ledger.
Where the tape and the public record meet
Peter says "we've built five and we're building two more in the US" (EP289 0:12:34). As of
2026-09-29 the company's own site agrees: five centres listed (Dallas, New York, Orlando, Naples,
Houston) and two "coming soon" (Miami, Los Angeles). Press reporting in 2025 gave other counts; the
site is the current primary source. The resort partner ("the estates") and the Greece conversation remain unverified.
Funding (secondary, TechCrunch 13 Aug 2025): an $18M Series B led by EOS Ventures, on a reported ~$80M Series A. The stated use of proceeds includes a clinic development programme to train other medical facilities in its methods, i.e. the franchise/licensing move was the funded plan before it was said on air.
What to take from it
Three things, none of which is a number.
- The unit being sold is the operating system, not the clinic. That is the same structure the longevity lab is building toward (a protocol, a norms table and a test base), and it is being validated by someone with more capital and more distribution.
- The franchise window is datable. ~March–June 2027 for an open call. It costs nothing to watch, and it will show what a licensed longevity protocol is priced and packaged as.
- Their evidence is marketing, and ours does not have to be. The studio battery's norms are published and cited. Two brain-age numbers, four plaque numbers and an 88% with no denominator, set next to a grip test scored against 25,000 people, is the contrast.
Where it came up
- Moonshots #289
0:12:23the franchise plan ·0:58:30nano villages ·1:05:03the blue-zone question ·1:10:17the cardiac ad - Brain-age read A (46%): EP248, EP256, EP260, EP265, EP269, EP273, EP278, EP282, Moonshots, 5 September 2026 — Fable 5.1, GPT-6 Astra, the Cybercab takeover, Moonshots #290, the 15 Oct 2026 episode (
1:13:44–1:15:22, the CMO on camera), Moonshots #307, Moonshots #308 - Brain-age read B (26%): EP240, EP249, EP257, EP261, EP270, EP271, EP275, EP277, EP279, Moonshots #283, Moonshots, 9 September 2026 — Agents hijack a German wiki, Jensen declares AGI, Navier–Stokes, Moonshots #291, EP298, Moonshots #303, Moonshots #304, Moonshots #309
- Cardiac read (88% / 23%): EP247, EP259, EP263, EP264, EP268, moonshots 274, EP281, Moonshots #285, Moonshots #289, Moonshots #293, the 7 Oct episode, Moonshots #306
- Cancer read (3.3%): EP242, EP246, EP253, EP258, EP262, EP267, EP272, EP276, EP280, Moonshots #284, EP288, the 19 Sep episode, the 3 Oct episode, Moonshots #305
- EP261
1:08:33network kibbutzes · EP2351:38:20disclosed as a portfolio company - Standing: "a part of my medical team", Moonshots #283
★ The 2025 baseline — Moonshots (2025-06-25) — Harvard Prof Reveals Age-Reversing Science to Look & Feel Younger w/ David Sinclair, read end to end 2026-09-30
The oldest Fountain Life material we hold, by ten months. It is a useful baseline because the ad read is the old one and the numbers are different — which is itself evidence on the stability question this page exists to hold.
| what was said | ts | read |
|---|---|---|
| the ad read: "70% of heart attacks have no precedent, no pain, no shortness of breath. And half of those people with a heart attack never wake up. You don't feel cancer until stage three or stage 4" | 1:19:06 |
⚠️ A different script from the 2026 reads. None of the 2026 figures (46% / 26% / 88% / 23% / 3.3%) appear. Unverified at source |
| founders named in the read | 1:19:28 |
"a group of us including Tony Robbins, Bill Cap [Kapp]**, and Bob Heruri* [Hariri] founded Fountain Life"* |
| ★ the scan spec, given unprompted as content, not as an ad | 1:35:13 |
"we get 200 gigabytes of data. It's like one of the most complete data uploads you can possibly do in 5 hours. full body MRI, brain, brain vascule, a coronary CT… low-dose lung CT… dexa scan, metabolomics, 140 blood biomarkers, your gut microbiome, retinal scan, skin scan" |
| ★ a member-outcome claim, pre-publication | 1:35:03 |
"one of the things we just are getting ready to publish this data at Fountain Life" → "We looked at what correlates highest with heart disease, and it wasn't LP little A or triglycerides or LDL or HDL. It was your hemoglobin A1C" 1:36:38. ⚠️ Announced as forthcoming in June 2025. Check whether it ever published |
| soft plaque vs calcified, the clinical argument the coronary CT is sold on | 1:35:24 |
"soft plaque is what kills you these days. And if you have a high calcium score, it doesn't mean much unless the calcium's blocking your coronary artery" |
| ★ the staffing figure — the largest he has given | 2:08:20 |
"I have an army of doctors I hire. I have 30 of them that working for me at [Foun]tain Life." Immediately followed by "But not everyone can do that." |
| a free scan offered to the guest on air | 1:36:00 |
"When am I going to get a scan?" — "Dude, please come. … as my guest" |
| the 2025 footprint | 1:36:06 |
operational: Naples, Orlando, Dallas, New York. Opening: Houston (end 2025), Miami, LA (Q1 2026). ⚠️ A 2025 snapshot — diff against the current centre list, and against the EP289 franchise plan |
| stem cells | 0:37:50 |
"presumably Fountain Life is going to get into that" — "Yeah… hopefully the most advanced stem cell therapeutics available, as well as other cellular med like NK cell supplementation". Aspirational in 2025. Shipped, in part (checked 2026-10-17): the home page says "New Stem Cell Therapies now available at selected centers" with its own "not FDA approved" note, and the shop lists Placental Stem Cell IV Therapy at $1,500. No NK-cell product found on the site or in the shop |
What the baseline adds to the stability question. The 2026 ad reads are unstable against each other (46% vs 26%, two days apart). The 2025 read shows something different and arguably worse for verification: the script is entirely different, and none of its numbers survive into 2026. A sponsor read whose figures are fully replaced within a year, with no published study behind either generation, is not a source. → the data table above, and Moonshots: the disclosures ledger.
Corpus and read depth. 109 Moonshots transcripts indexed (EP162, April 2025, to Moonshots #309, 7 Nov 2026, the protocol directory plus its backfill set). The channel feed was last checked on 2026-11-10: 111 episodes on disk, none missing; EP308 and EP309 were swept for this page, and on 2026-11-16 EP310 and EP311 were swept as well. This is not the whole run of the show. The ad reads were found by pattern sweep and each hit was read in context; the passages quoted above were read in full. Timestamps are from the auto-caption transcripts.
⚠️ Unverified
- Everything quoted from tape is from auto-captions and has no speaker labels.
- The franchise timeline, the resort group "the estates" and the Greece conversation are Peter's statements on EP289 and nothing more.
- Funding figures are from press reporting, not filings.
- Prices are shop listings on one date; the deposit/balance structure is inferred from listing names.
- Every member-outcome figure is Fountain Life's own and unreviewed.
EP304 (Moonshots #304, aired 2026-10-21): read B again, by the CMO, second episode running
- Sponsor read at
1:36:45, Dr. Dawn Mussallem on camera (caption "Don Mussalem"): "45% are entirely preventable… one quarter of our members had advanced brain age… We saw that we improved that brain age by 26%… the majority of those individuals" (1:37:40–1:38:13). Read B, 15th held episode (14 through Moonshots #303); the CMO has now said read B on two episodes in a row after saying read A (46%) on Moonshots #unnumbered. Still on no Fountain Life page. 🔴 never repeat.
How this page stays current
Weekly (the research archive, refresh: weekly). Every step is a diff, dated.
- Tape: grep the week's new the research archive for
fountain; for any read with a number, add it to the data table with episode and timestamp, and flag any figure not already listed. - Their numbers: WebFetch fountainlife.com (home, /how-it-works, /core, /apex, /base) and diff every percentage against the two data tables.
- Prices: WebFetch
https://shop.fountainlife.com/products.jsonand fountainlife.com/base; re-date any price that changed. - Publications: PubMed
"Fountain Life"[Affiliation]and the company's /news page; if a study or white paper appears for the 88%, 46% or 26%, move that row to "published" and link it. - Franchise: search for a Fountain Life franchise or "open call for interest" (window ~Mar–Jun 2027) and for new centres; update the dates and the centre count.
- The 2025 open item (added 2026-09-30): on Moonshots (2025-06-25) — Harvard Prof Reveals Age-Reversing Science to Look & Feel Younger w/ David Sinclair
1:35:03Peter says the member-outcome data — the HbA1c-as-top-correlate finding — is "getting ready to publish". Check each week whether it ever did. A forthcoming study announced in June 2025 and still unpublished is a stronger finding than the unstable ad percentages, because it has a date on it.
EP305 (Moonshots #305, aired 2026-10-23): the cancer read, voiced by the CMO
- Where:
1:45:24–1:47:12, inside the flow between the scorpion-toxin item and the phage item, introduced "Welcome to the health section of Moonshots brought to you by Fountain Life", with the CMO (caption "Dr. Don Mucalem"; Dr. Dawn Mussallem). - The line: "I know from the member database that we've have at Fountain are members who come in who think they're healthy. It turns out 3.3% of them have a cancer in their body they don't know about" (
1:45:46); the CMO, "over 3.3% were found to have these cancers that were otherwise wouldn't have been found or detected" (1:46:19). Her caveat, unusual for the read: "these are not studies that insurance would yet be covering. But the goal is to collect these numbers, do the research" (1:46:51). - Status: the 3.3% row on this page is unchanged (company-database figure, no denominator, not published). EP303 and EP304 both carried brain-age read B (26%); EP305 returns to the cancer read. 🔴 Barred from any Gonçalo copy. The closing instruction, "It's your obligation to know" (
1:47:01), is the host's.
EP306 (Moonshots #306, aired 2026-10-28): the cardiac read, voiced by the CMO
- Where:
1:45:35–1:47:21, right after the fine-structure-constant segment, introduced "Welcome to the health section of Moonshots brought to you by Fountain Life" with the stated caveat "for informational purposes only and is not medical advice". The host gives his own role ("I'm a co-founder … at Fountain Life", caption garbled); the CMO is on camera (caption "Dr. Don Mucalem"; Dr. Dawn Mussallem). - The numbers: "50% of people die of heart attacks with no warning signs" (
1:46:16); "when we do this CT angiography with AI analytics, we are actually finding that 88% of people coming in have detectable coronary artery disease" (1:46:36); "23% of those individuals had soft plaque … the plaque that would not traditionally be seen on CT looking at calcium scores alone" (1:46:48). - Status: all three rows on this page are unchanged: the 88% has no denominator, the 23% is not published, the 50% is unsourced. Cardiac read, 12th held episode. The CTA is fountainlife.com/peter. 🔴 Barred from any Gonçalo copy.
EP307 (Moonshots #307, aired 2026-10-31): brain-age read A, voiced by the CMO
- Where:
1:40:49–1:42:41, after the Cambridge driverless-taxi story. Host: "I'm a co-founder [and chairman] at Fountain Life" (caption "Inclient"); the CMO is on camera (caption "Dr. Don Malem"). - The numbers: "45% of dementia cases are entirely preventable with lifestyle" (
1:41:45); "a quarter of our members had advanced brain age. But over 13 months… we were able to improve the brain age in 46% of those individuals" (1:41:56–1:42:07). - Status: the 46% row is unchanged (member figure, no denominator; read A). New: the 45% overstates its apparent source. The 2024 Lancet Commission says ~45% "could theoretically be prevented or delayed" across 14 modifiable risk factors, several of them not lifestyle (education, hearing and vision loss, LDL, air pollution, head injury). It is an attributable fraction, not "entirely preventable". 🔴 Barred from any Gonçalo copy.
EP308 (Moonshots #308, aired 2026-11-04) — the ad read, logged
Health-section read with "Dr. Don Saladino" per the (machine-translated) captions [attr?] (1:19:03–1:21:02): "45% cases of dementia can be completely prevent through lifestyle", "a quarter of our participants had advanced brain age", "we succeeded improve brain age in 46% of these people". The same 46%/25% pairing as the EP307 read — consistent with the standing finding that 46% and 26% are two different ad reads. Peter restates co-founder status (1:19:14). Read A, 13th held episode. Sponsor numbers, barred from Gonçalo copy.
EP309 (Moonshots #309, aired 2026-11-07): brain-age read B, voiced by the CMO
- Where:
1:25:03–1:27:02(whisper timestamps), introduced "Welcome to the health section of moonshots brought to you by fountain life" with the "not medical advice" caveat; the host gives his role ("I'm a co-founder [and chairman] at fountain life", caption garbled) and calls the CMO "a part of my medical team" (caption "Don musalem"; Dr. Dawn Mussallem). - The numbers: "the conservative estimates are that 45 percent are entirely preventable" (
1:26:09); "One quarter of our members had advanced brain age" (1:26:20); "we improved that brain age by 26 … That is a big big number to show that the majority of those individuals were able actually to improve the brain age" (1:26:32–1:26:45). - Status: the 26% row is unchanged (on no Fountain Life page or release; "by 26%" called "the majority"). Read B, 16th held episode, three days after the same CMO's read A on Moonshots #308. The 45% carries the same overstatement noted under EP307. The CTA is fountainlife.com/peter. 🔴 Barred from any Gonçalo copy.
EP310 (Moonshots #310, aired 2026-11-11): the cancer read again, the same segment as EP305
- Where:
2:05:49–2:07:55, introduced "Welcome to the health section of Moonshots brought to you by Fountain Life" with the "not medical advice" caveat; the host gives his co-founder role (caption "Inclient"); the CMO is on camera (caption "Dr. Don Mucalem"; Dr. Dawn Mussallem). - The numbers: "3.3% of them have a cancer in their body they don't know about" (
2:06:33); "over 3.3% were found to have these cancers that were otherwise wouldn't have been found" (2:06:53–2:07:04); method given as full-body MRI plus early cancer detection screening (2:07:14–2:07:24). - Status: the 3.3% row is unchanged (company-database figure, no denominator, not published). The caption text matches the Moonshots #305 read word for word: a segment aired again, not a new statement. Cancer read, 15th held episode. Moonshots #311 (aired 2026-11-13) carried no Fountain Life read. The CTA is fountainlife.com/peter. 🔴 Barred from any Gonçalo copy.